Abiopharma

🔍 McPherson Scott E (Executive)

Company: Performance Food Group Co (PFGC)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 13,766 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: A | equity_swap_involved: false | shares_owned_after: 192,201.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,692 shares of Common Stock at $104.54 per share (Direct)
  Date: 2026-08-18 | Code: F | equity_swap_involved: false | shares_owned_after: 187,509.00 | transaction_form_type: 4
• Acquired 22,958 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: A | equity_swap_involved: false | shares_owned_after: 210,467.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,321 shares of Common Stock at $103.34 per share (Direct)
  Date: 2026-08-19 | Code: F | equity_swap_involved: false | shares_owned_after: 209,146.00 | transaction_form_type: 4

Footnotes:

• F1: Represents a grant of performance-based restricted stock under the 2015 Omnibus Incentive Plan that vested on the date the Human Capital and Compensation Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals, which are based on relative total shareholder return, were attained for the performance period of July 2, 2023, to June 27, 2026.
• F2: Represents a grant of restricted stock that vests in three equal annual installments beginning on August 18, 2027.
• REMARKS: President and Chief Executive Officer